Demonstrates a novel immunosensor to enhance TTX detection in food safety, suggesting improved on-site testing capabilities.
Tetrodotoxin (TTX) is a potent marine neurotoxin, necessitating sensitive and user-friendly on-site assays. To address long workflows of traditional immunoassays and limited signal amplification in colorimetric microfluidics, we developed a nanozyme-catalyzed colorimetric magnetic microfluidic immunosensor (Nano-CMI). This platform combines an aptamer–antibody sandwich capture format with catalytic amplification via AuNR@Pt@m-SiO2 (APMS) nanozymes on a magnetically actuated microfluidic chip. Magnetic actuation simplifies sample handling and washing, while APMS catalysis enhances sensitivity and visual readout. The Nano-CMI has been used for the detection of TTX samples ranging from 0.2 to 20 ng/mL with a detection limit of 0.2 ng/mL in 10 min, following the linear equation: y = −31.14ln x + 110.15, and the entire “capture-reaction-detection” workflow can be completed within 1 h. With rapid response, minimal hands-on time, and robust performance, this platform offers a practical, high-sensitivity solution for on-site TTX screening in food safety and customs inspection.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: